Panacea Biotec gets nod for allotment of NCDs worth Rs 743 crore

09 Apr 2019 Evaluate

Panacea Biotec has received an approval for the allotment of 74,300 unrated, unlisted, redeemable, non-convertible debentures (NCDs), having the face value of Rs 1 lakh each, aggregating to Rs 743 crore on private placement basis. The Executive Committee of the Board of Directors of the Company at its meeting held on April 08, 2019, approved the same.


Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and biotechnology companies in India.

Panacea Biotec Share Price

346.70 -4.95 (-1.41%)
17-Dec-2025 11:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×